IGEA S.p.A. Via Parmenide, 10/A 41012 Carpi (MO) - Italy tel +39 059 699600 fax +39 059 695778 pec igeamedical.com@pec.it C.F. e P.I. 01021130362 € 168.776,00 i.v. REA 205183 Reg. Soc. Trib. 14968

CLINIPORATOR^®

ADAPTIVE ELECTROPORATION TECHNOLOGIES

The most widespread reversible electroporation technology, enabling the treatment of tumour nodules localised in skin and subcutis, mucous membranes and through surgical access to the parenchyma.

It is compatible with a wide range of electrodes designed for different therapeutic needs.

CONTACT A PRODUCT SPECIALIST

BROCHURE

TECHNICAL SHEET

CLINIPORATOR®

ADAPTIVE ELECTROPORATION TECHNOLOGIES

The most widespread reversible electroporation technology, enabling the treatment of tumour nodules localised in skin and subcutis, mucous membranes, and through surgical access to the parenchyma.

It is compatible with a wide range of electrodes designed for different therapeutic needs.

CONTACT A PRODUCT SPECIALIST

DOWNLOAD BROCHURE

TECHNICAL SHEET

Fast and effective electroporation

Electroporation of large volumes is completed within minutes.

The speed of execution makes it possible to treat numerous tumour lesions in a single session.

Features

Pulse

Generator

It delivers electrical impulses by means of multi-needle applicators arranged according to a predefined geometry (PRE-SET).

Touch

screen

Simple and immediate graphical interface.

Cardiac

synchronisation

Using an R-wave detector, electrical pulses are delivered during the absolute refractory period of the heart.

Real-time

measurement

Real-time measurement of the electrical current flowing through the tumour tissue immediately provides the user with feedback on the effectiveness of electroporation.